TY - STD TI - Wang K, Shun-Shin M, Gill P, Perera R, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database Syst Rev. 2012; 4:002744. doi:http://dx.doi.org/10.1002/14651858.cd002744.pub4. UR - http://dx.doi.org/10.1002/14651858.cd002744.pub4 ID - ref1 ER - TY - STD TI - Ebell MH, Call M, Shinholser J. Effectiveness of oseltamivir in adults: a meta-analysis of published and unpublished clinical trials. Fam Pract. 2012; 30(2):125–33. doi:http://dx.doi.org/10.1093/fampra/cms059. UR - http://dx.doi.org/10.1093/fampra/cms059 ID - ref2 ER - TY - STD TI - Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya IJ, Mahtani KR, Nunan D, et al.Neuraminidase inhibitors for preventing and treating influenza in adults and children. Cochrane Database Syst Rev. 2014; 4:008965. doi:http://dx.doi.org/10.1002/14651858.cd008965.pub4. UR - http://dx.doi.org/10.1002/14651858.cd008965.pub4 ID - ref3 ER - TY - STD TI - Dobson J, Whitley RJ, Pocock S, Monto AS. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet. 2015; 385(9979):1729–1737. doi:http://dx.doi.org/10.1016/s0140-6736(14)62449-1. UR - http://dx.doi.org/10.1016/s0140-6736(14)62449-1 ID - ref4 ER - TY - STD TI - McVernon J, McCaw JM, Nolan TM. Modelling strategic use of the national antiviral stockpile during the CONTAIN and SUSTAIN phases of an Australian pandemic influenza response. Aust N Z J Public Health. 2010; 34(2):113–9. doi:http://dx.doi.org/10.1111/j.1753-6405.2010.00493.x. UR - http://dx.doi.org/10.1111/j.1753-6405.2010.00493.x ID - ref5 ER - TY - STD TI - Moss R, McCaw JM, McVernon J. Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic. PLoS ONE. 2011; 6(2):14505. doi:http://dx.doi.org/10.1371/journal.pone.0014505. UR - http://dx.doi.org/10.1371/journal.pone.0014505 ID - ref6 ER - TY - STD TI - McCaw JM, Moss R, McVernon J. A decision support tool for evaluating the impact of a diagnostic-capacity and antiviral-delivery constrained intervention strategy on an influenza pandemic. Influenza Other Respir Viruses. 2011; 5:212–5. doi:http://dx.doi.org/10.1111/j.1750-2659.2011.00209.x. UR - http://dx.doi.org/10.1111/j.1750-2659.2011.00209.x ID - ref7 ER - TY - STD TI - Dafilis MP, Moss R, McVernon J, McCaw J. Drivers and consequences of influenza antiviral resistant-strain emergence in a capacity-constrained pandemic response. Epidemics. 2012; 4(4):219–26. doi:http://dx.doi.org/10.1016/j.epidem.2012.12.002. UR - http://dx.doi.org/10.1016/j.epidem.2012.12.002 ID - ref8 ER - TY - BOOK PY - 2015 DA - 2015// TI - Wellcome Trust: Use of Neuraminidase Inhibitors in Influenza PB - The Academy of Medical Sciences and Wellcome Trust CY - London ID - ref9 ER - TY - STD TI - Marra F, Chong M, Henry B, Patrick DM, Kendall P. Effectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada. J Antimicrob Chemother. 2013; 69(5):1397–1406. doi:http://dx.doi.org/10.1093/jac/dkt496. UR - http://dx.doi.org/10.1093/jac/dkt496 ID - ref10 ER - TY - STD TI - Department of Health: Australian health management plan for pandemic influenza. Technical report, Australian Government 2014. http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-ahmppi.htm. Accessed 29 Sept 2016. UR - http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-ahmppi.htm ID - ref11 ER - TY - STD TI - Australian Bureau of Statistics: Australian Demographic Statistics, Jun 2014. Technical Report 3101.0, Australian Bureau of Statistics 2014. http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Jun%202014. Accessed 29 Sept 2016. UR - http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Jun%202014 ID - ref12 ER - TY - STD TI - Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Al Khuwaitir TSA, Al Mamun A, Anovadiya AP, Azziz-Baumgartner E, Báez C, Bassetti M, et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med. 2014; 2(5):395–404. doi:http://dx.doi.org/10.1016/s2213-2600(14)70041-4. UR - http://dx.doi.org/10.1016/s2213-2600(14)70041-4 ID - ref13 ER - TY - STD TI - Muthuri SG, Venkatesan S, Myles PR, Leonardi-Bee J, Lim WS, Mamun AA, Anovadiya AP, Araújo WN, Azziz-Baumgartner E, Báez C, et al.Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an IPD meta-analysis. Influenza Other Respir Viruses. 2015. doi:http://dx.doi.org/10.1111/irv.12363. Accepted, unedited article published online and citable. UR - http://dx.doi.org/10.1111/irv.12363 ID - ref14 ER - TY - STD TI - Australian Bureau of Statistics: Australian Social Trends: Doctors and Nurses. Technical report, Australian Bureau of Statistics 2013. http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4102.0Main+Features20April+2013. Accessed 29 Sept 2016. UR - http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4102.0Main+Features20April+2013 ID - ref15 ER - TY - STD TI - Higa F, Tateyama M, Tomishima M, Mukatake S, Yamashiro T, Owan T, Haranaga S, Fujita J. Role of neuraminidase inhibitor chemoprophylaxis in controlling nosocomial influenza: an observational study. Influenza Other Respir Viruses. 2011; 6(4):299–303. doi:http://dx.doi.org/10.1111/j.1750-2659.2011.00311.x. UR - http://dx.doi.org/10.1111/j.1750-2659.2011.00311.x ID - ref16 ER - TY - STD TI - McCaw JM, McVernon J. Prophylaxis or treatment? optimal use of an antiviral stockpile during an influenza pandemic. Math Biosci. 2007; 209(2):336–60. doi:http://dx.doi.org/10.1016/j.mbs.2007.02.003. UR - http://dx.doi.org/10.1016/j.mbs.2007.02.003 ID - ref17 ER - TY - STD TI - McCaw JM, Glass K, Mercer GN, McVernon J. Pandemic controllability: a concept to guide a proportionate and flexible operational response to future influenza pandemics. J Public Health. 2014; 36(1):5–12. doi:http://dx.doi.org/10.1093/pubmed/fdt058. UR - http://dx.doi.org/10.1093/pubmed/fdt058 ID - ref18 ER - TY - STD TI - Van Kerkhove MD, Vandemaele KAH, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, Carlino LO, Owen R, Paterson B, Pelletier L, et al.Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: A global pooled analysis. PLoS Med. 2011; 8(7):1001053. doi:http://dx.doi.org/10.1371/journal.pmed.1001053. UR - http://dx.doi.org/10.1371/journal.pmed.1001053 ID - ref19 ER - TY - STD TI - Falagas ME, Koletsi PK, Vouloumanou EK, Rafailidis PI, Kapaskelis AM, Rello J. Effectiveness and safety of neuraminidase inhibitors in reducing influenza complications: a meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2010; 65(7):1330–1346. doi:http://dx.doi.org/10.1093/jac/dkq158. UR - http://dx.doi.org/10.1093/jac/dkq158 ID - ref20 ER - TY - STD TI - Pandemic Influenza Preparedness Team: The National Pandemic Flu Service: an evaluation. Technical Report 15652, UK Department of Health 2011. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/215679/dh_125338.pdf. Accessed 29 Sept 2016. UR - https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/215679/dh_125338.pdf ID - ref21 ER - TY - STD TI - Cauchemez S, Ferguson NM, Wachtel C, Tegnell A, Saour G, Duncan B, Nicoll A. Closure of schools during an influenza pandemic. Lancet Infect Dis. 2009; 9(8):473–81. doi:http://dx.doi.org/10.1016/s1473-3099(09)70176-8. UR - http://dx.doi.org/10.1016/s1473-3099(09)70176-8 ID - ref22 ER - TY - STD TI - Verikios G, McCaw JM, McVernon J, Harris AH. H1N1 influenza and the Australian macroeconomy. J Asia Pac Econ. 2012; 17(1):22–51. doi:http://dx.doi.org/10.1080/13547860.2012.639999. UR - http://dx.doi.org/10.1080/13547860.2012.639999 ID - ref23 ER - TY - STD TI - Brown ST, Tai JH, Bailey RR, Cooley PC, Wheaton WD, Potter MA, Voorhees RE, LeJeune M, Grefenstette JJ, Burke DS, et al.Would school closure for the 2009 H1N1 influenza epidemic have been worth the cost?: a computational simulation of Pennsylvania. BMC Public Health. 2011; 11(1):353. doi:http://dx.doi.org/10.1186/1471-2458-11-353. UR - http://dx.doi.org/10.1186/1471-2458-11-353 ID - ref24 ER - TY - STD TI - McVernon J, Mason K, Petrony S, Nathan P, LaMontagne AD, Bentley R, Fielding J, Studdert DM, Kavanagh A. Recommendations for and compliance with social restrictions during implementation of school closures in the early phase of the influenza A (H1N1) 2009 outbreak in Melbourne, Australia. BMC Infect Dis. 2011; 11(1):257. doi:http://dx.doi.org/10.1186/1471-2334-11-257. UR - http://dx.doi.org/10.1186/1471-2334-11-257 ID - ref25 ER - TY - STD TI - Leung GM, Nicoll A. Reflections on pandemic (H1N1) 2009 and the international response. PLoS Med. 2010; 7(10):1000346. doi:http://dx.doi.org/10.1371/journal.pmed.1000346. UR - http://dx.doi.org/10.1371/journal.pmed.1000346 ID - ref26 ER - TY - STD TI - Caley P, Philp DJ, McCracken K. Quantifying social distancing arising from pandemic influenza. J R Soc Interface. 2008; 5(23):631–9. doi:http://dx.doi.org/10.1098/rsif.2007.1197. UR - http://dx.doi.org/10.1098/rsif.2007.1197 ID - ref27 ER - TY - STD TI - Hardelid P, Andrews N, Hoschler K, Stanford E, Baguelin M, Waight P, Zambon M, Miller E. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza AH1N1 2009. Health Technol Assess. 2010; 14(55):3. doi:http://dx.doi.org/10.3310/hta14550-03. UR - http://dx.doi.org/10.3310/hta14550-03 ID - ref28 ER - TY - JOUR AU - Mytton, O. T. AU - Rutter, P. D. AU - Donaldson, L. J. PY - 2012 DA - 2012// TI - Influenza A(H1N1)pdm09 in England, 2009 to 2011: a greater burden of severe illness in the year after the pandemic than in the pandemic year JO - Euro Surveill VL - 17 ID - Mytton2012 ER - TY - JOUR AU - McVernon, J. AU - Laurie, K. AU - Nolan, T. AU - Owen, R. AU - Irving, D. AU - Capper, H. AU - Hyland, C. AU - Faddy, H. AU - Carolan, L. AU - Barr, I. AU - Kelso, A. PY - 2010 DA - 2010// TI - Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October–December 2009 JO - Euro Surveill VL - 15 ID - McVernon2010 ER - TY - STD TI - McVernon J, Laurie K, Faddy H, Irving D, Nolan T, Barr I, Kelso A. Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second year=2010 pandemic wave in Australia. Influenza Other Respir Viruses. 2013; 8(2):194–200. doi:http://dx.doi.org/10.1111/irv.12225. UR - http://dx.doi.org/10.1111/irv.12225 ID - ref31 ER - TY - STD TI - Chowell G, Bettencourt LMA, Johnson N, Alonso WJ, Viboud C. The 1918–1919 influenza pandemic in England and Wales: spatial patterns in transmissibility and mortality impact. Proc R Soc B. 2008; 275(1634):501–9. doi:http://dx.doi.org/10.1098/rspb.2007.1477. UR - http://dx.doi.org/10.1098/rspb.2007.1477 ID - ref32 ER - TY - STD TI - Mathews JD, McBryde ES, McVernon J, Pallaghy PK, McCaw JM. Prior immunity helps to explain wave-like behaviour of pandemic influenza in 1918–9. BMC Infect Dis. 2010; 10(1):128. doi:http://dx.doi.org/10.1186/1471-2334-10-128. UR - http://dx.doi.org/10.1186/1471-2334-10-128 ID - ref33 ER - TY - STD TI - Bolton KJ, McCaw JM, McVernon J, Mathews JD. The influence of changing host immunity on 1918–19 pandemic dynamics. Epidemics. 2014; 8:18–27. doi:http://dx.doi.org/10.1016/j.epidem.2014.07.004. UR - http://dx.doi.org/10.1016/j.epidem.2014.07.004 ID - ref34 ER - TY - STD TI - Miller MA, Viboud C, Balinska M, Simonsen L. The signature features of influenza pandemics — implications for policy. N Engl J Med. 2009; 360(25):2595–598. doi:http://dx.doi.org/10.1056/nejmp0903906. UR - http://dx.doi.org/10.1056/nejmp0903906 ID - ref35 ER - TY - STD TI - McLean E, Pebody RG, Campbell C, Chamberland M, Hawkins C, Nguyen-Van-Tam JS, Oliver I, Smith GE, Ihekweazu C, Bracebridge S, Maguire H, Harris R, Kafatos G, White PJ, Wynne-Evans E, Green J, Myers R, Underwood A, Dallman T, Wreghitt T, Zambon M, Ellis J, Phin N, Smyth B, McMenamin J, Watson JM. Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect. 2010; 138(11):1531–1541. doi:http://dx.doi.org/10.1017/s0950268810001366. UR - http://dx.doi.org/10.1017/s0950268810001366 ID - ref36 ER - TY - STD TI - ANZICS: ANZICS 2014 annual report. Technical report, ANZICS 2014. http://www.anzics.com.au/Downloads/ANZICS%20Annual%20Report%202014.pdf. Accessed 29 Sept 2016. UR - http://www.anzics.com.au/Downloads/ANZICS%20Annual%20Report%202014.pdf ID - ref37 ER - TY - STD TI - AIHW: Australia’s hospitals 2009-10 at a glance. Technical report, AIHW 2011. http://www.aihw.gov.au/publication-detail/?id=10737418683. Accessed 29 Sept 2016. UR - http://www.aihw.gov.au/publication-detail/?id=10737418683 ID - ref38 ER - TY - STD TI - AIHW: Australian hospital statistics 2011-12: Emergency department care. Health Services Series HSE 126. AIHW. 2012. http://www.aihw.gov.au/publication-detail/?id=10737423042. Accessed 29 Sept 2016. UR - http://www.aihw.gov.au/publication-detail/?id=10737423042 ID - ref39 ER - TY - STD TI - AHWAC: Health workforce planning and models of care in emergency departments. Technical Report 2006.X. AHWAC. 2006. http://docplayer.net/15513519-Health-workforce-planning-and-models-of-care-in-emergencydepartments.html. Accessed 29 Sept 2016. UR - http://docplayer.net/15513519-Health-workforce-planning-and-models-of-care-in-emergencydepartments.html ID - ref40 ER - TY - STD TI - AIHW: Australia’s health 2012, Australia’s Health Series AUS 156. AIHW. 2012. http://www.aihw.gov.au/publication-detail/?id=10737422172. Accessed 29 Sept 2016. UR - http://www.aihw.gov.au/publication-detail/?id=10737422172 ID - ref41 ER -